Document Detail


Cluster protocols in SCIT: enough evidence for practical use?
MedLine Citation:
PMID:  20410818     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE OF REVIEW: The review provides a comprehensive evaluation of Cluster schedules in subcutaneous-specific immunotherapy (SCIT) in terms of the safety profile and onset of clinical and immunological effects. RECENT FINDINGS: Recent major clinical studies could clearly reveal that Cluster schedules with both (semi-)depot-allergen preparations and chemically modified allergen preparations ('allergoids') are well tolerated therapeutic options in SCIT comparable to the safety profile of conventional build-up schedules. Moreover, preliminary data indicate that these accelerated protocols result in a more rapid achievement of clinical and immunological effects. SUMMARY: Conventional schedules in SCIT have the disadvantage of both a high expenditure of time and the need for a high patient compliance. In accelerated cluster schedules two to three injections are administered sequentially per treatment day (with an interval of 30 min between the injections) in weekly intervals aimed to reach the maintenance dose of SCIT in a short time interval. Recent studies indicate that these accelerated SCIT protocols result in a more rapid achievement of clinical and immunological effects than conventional schedules. Moreover, the safety profile is comparable between conventional and cluster SCIT.
Authors:
Oliver Pfaar; Sarah Leitzbach; Karl Hörmann; Ludger Klimek
Related Documents :
9717818 - Superantigen-targeted therapy: phase i escalating repeat dose trial of the fusion prote...
12218268 - Phase i study of weekly irinotecan combined with weekly cisplatin in patients with adva...
7355248 - Methodology of phase i study in japan.
20091088 - A phase i study of pemetrexed in patients with relapsed or refractory acute leukemia.
18803258 - No carry over of unmetabolised deoxynivalenol in milk of dairy cows fed high concentrat...
3365068 - Hemodynamic effects of a dihydropyridine calcium antagonist, nb-818 (npk-1886) in anest...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Current opinion in allergy and clinical immunology     Volume:  10     ISSN:  1473-6322     ISO Abbreviation:  Curr Opin Allergy Clin Immunol     Publication Date:  2010 Jun 
Date Detail:
Created Date:  2010-04-30     Completed Date:  2010-09-16     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100936359     Medline TA:  Curr Opin Allergy Clin Immunol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  188-93     Citation Subset:  IM    
Affiliation:
Centre for Rhinology and Allergology (Wiesbaden) of the Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Mannheim, D-65183 Wiesbaden, Germany. oliver.pfaar@allergiezentrum.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Allergens / administration & dosage,  immunology
Clinical Protocols
Clinical Trials as Topic
Desensitization, Immunologic* / adverse effects,  methods
Humans
Injections, Subcutaneous
Patient Compliance
Treatment Outcome
Chemical
Reg. No./Substance:
0/Allergens

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Purified vs. nonpurified venom immunotherapy.
Next Document:  Food allergy and eosinophilic esophagitis.